Monographie - Morphine tartrate - Stabilis 4.0

Viimeisin päivitys :
19/11/2024

Analgeetit

Morphine tartrate

Injektioneste

Stabilius liuoksessa

Stabilius seoksissa

Tekijät, jotka vaikuttavat stabiliuteen

Yhteensopivuus

Antotapa

Viitteet

pdf

Kemiallinen rakenne

Kauppanimi

Kauppanimi

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Morphine tartrate

Australia

Viitteet

Injektioneste

Viitteet : Morphine tartrate

	tyyppi	julkaisu
519	Lehti	Poggi GL. Compatibility of morphine tartrate admixtures in polypropylene syringes. Aust J Hosp Pharm 1991 ; 21: 316.
920	Lehti	Targett PL, Keefe PA, Merridew CG. Stability of two concentrations of morphine tartrate in 10 mL polypropylene syringes. Aust J Hosp Pharm 1997 ; 27: 452-454.
980	Lehti	Ambados F. Compatibility of morphine and ketamine for subcutaneous infusion. Aust J Hosp Pharm 1995 ; 25: 352.
1864	Lehti	Lau MH, Hackman C, Morgan DJ. Compatibility of ketamine and morphin injections. Pain 1998 ; 75: 389-390.
2083	Lehti	La Forgia SP, Sharley NA, Burgess NG, Doecke CJ. Stability and compatibility of morphine, midazolam and bupivacaine combinaisons for iontravenous infusion. J Pharm Pract and Res 2002 ; 32: 65-68.
3474	Laboratorio	Fluorouracil - Summary of Product Characteristics Accord Healthcare Limited 2009
3504	Laboratorio	Parecoxib (Dynastat®) - Summary of Product Characteristics Pfizer 2012
3644	Laboratorio	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010
3675	Laboratorio	Thiopental sodium - Summary of Product Characteristics Archimedes Pharma UK Ltd 2015
3838	Laboratorio	Magnesium Sulphate - Summary of Product Characteristics Martindale Pharmaceuticals Ltd 2007
3934	Laboratorio	Eptifibatide (Integrilin®) - Résumé des caractéristiques du produit GlaxoSmithKline Laboratoire 2016

Mentions Légales